News

Filter

Current filters:

Achillion Pharmaceuticals

Achillion a good candidate for collaboration or takeover based on hepatitis C candidate, says Edison

Achillion a good candidate for collaboration or takeover based on hepatitis C candidate, says Edison

29-09-2014

Achillion Pharmaceuticals is in a prime position to develop its own all-oral hepatitis C treatment as…

Achillion PharmaceuticalsFinancialMarkets & MarketingNephrology and HepatologyPharmaceuticalUSA

US FDA puts clinical hold on Achillion's sovaprevir on safety concerns

02-07-2013

USA-based Achillion Pharmaceuticals (Nasdaq: ACHN) announced yesterday (July 1) that the US Food and…

Achillion PharmaceuticalsAntibiotics and Infectious diseasesatazanivirPharmaceuticalRegulationsovaprevir

Achillion Pharma moves up as a contender in the HCV market, GlobalData believes

02-10-2012

On September 27, Achillion Pharmaceuticals (Nasdaq: ACHN) released news of positive results surrounding…

ACH-3102Achillion PharmaceuticalsAnti-viralsBiotechnologyMergers & AcquisitionsPharmaceuticalResearch

US FDA fast-tracks Achillion's hepatitis C drug candidate

15-05-2012

USA-based Achillion Pharmaceuticals (Nasdaq: ACHN) says it has received Fast Track designation from the…

Achillion PharmaceuticalsAnti-viralsNorth AmericaPharmaceuticalRegulation

Back to top